
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
The Readout Loud
00:00
Navigating Biotech Funding Challenges
This chapter examines a significant fundraising announcement by a biotech startup that raised $213 million but faced operational setbacks shortly after. It discusses the implications of funding structures, investor sentiment shifts, and the challenges confronting biotech companies in a turbulent financial landscape.
Transcript
Play full episode